ZA945546B - Antifugal nail solution - Google Patents

Antifugal nail solution

Info

Publication number
ZA945546B
ZA945546B ZA945546A ZA945546A ZA945546B ZA 945546 B ZA945546 B ZA 945546B ZA 945546 A ZA945546 A ZA 945546A ZA 945546 A ZA945546 A ZA 945546A ZA 945546 B ZA945546 B ZA 945546B
Authority
ZA
South Africa
Prior art keywords
antifugal
nail solution
nail
solution
tioconazole
Prior art date
Application number
ZA945546A
Other languages
English (en)
Inventor
Debbie L Burnett
Darius D Dubash
Athanasios S Ladas
Teresa J De Vincentis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA945546B publication Critical patent/ZA945546B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seeds, Soups, And Other Foods (AREA)
ZA945546A 1993-07-28 1994-07-27 Antifugal nail solution ZA945546B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/097,422 US5391367A (en) 1993-07-28 1993-07-28 Antifungal nail solution

Publications (1)

Publication Number Publication Date
ZA945546B true ZA945546B (en) 1996-01-29

Family

ID=22263261

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945546A ZA945546B (en) 1993-07-28 1994-07-27 Antifugal nail solution

Country Status (14)

Country Link
US (1) US5391367A (fr)
EP (1) EP0711140B1 (fr)
JP (1) JP3064423B2 (fr)
KR (1) KR0179465B1 (fr)
AT (1) ATE185066T1 (fr)
AU (1) AU684826B2 (fr)
CA (1) CA2168248C (fr)
DE (1) DE69420967T2 (fr)
DK (1) DK0711140T3 (fr)
ES (1) ES2137372T3 (fr)
GR (1) GR3031897T3 (fr)
NZ (1) NZ267489A (fr)
WO (1) WO1995003775A1 (fr)
ZA (1) ZA945546B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916545A (en) * 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
US6264628B1 (en) 1998-08-06 2001-07-24 Profoot, Inc. Set depth nail notcher and method for treating nail fungus
US6287276B1 (en) 1998-08-06 2001-09-11 Profoot, Inc. Set depth nail notcher and method for treating nail fungus
US6572580B2 (en) 1998-08-06 2003-06-03 Profoot, Inc. Set depth nail notcher with patch system and method for treating nail fungus
US6403063B1 (en) 1999-07-26 2002-06-11 Kenneth I. Sawyer Method of treating nail fungus
US6495124B1 (en) 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
US6878365B2 (en) * 2001-03-10 2005-04-12 James Edward Brehove Topical application for treating toenail fungus
US6664292B2 (en) 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
US8404751B2 (en) * 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
DE10341944A1 (de) * 2003-09-11 2005-04-28 York Pharma Plc Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff
JP5059408B2 (ja) * 2004-08-05 2012-10-24 久光製薬株式会社 爪用外用剤
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
CN101115475A (zh) 2004-12-10 2008-01-30 塔利马治疗公司 用于治疗指甲单位病症的组合物和方法
US20060251593A1 (en) * 2005-04-07 2006-11-09 Work By Docs, Inc. Colored nail enamel treatment
WO2007077806A1 (fr) * 2005-12-28 2007-07-12 Teikoku Seiyaku Co., Ltd. Composition pharmaceutique pour application ungueale
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
JP2011051966A (ja) * 2009-09-03 2011-03-17 Daiya Seiyaku Kk 爪白癬治療用貼付剤
ES2369101B2 (es) 2010-05-07 2012-08-02 Universidade De Santiago De Compostela Sistema farmacéutico acuoso para la administración de fármacos en las uñas.
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
TW201410273A (zh) 2012-07-30 2014-03-16 Meiji Seika Pharma Co Ltd 抗白癬菌症貼附劑
JP6132842B2 (ja) * 2012-07-30 2017-05-24 Meiji Seikaファルマ株式会社 抗白癬菌症外用液剤
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2968886A1 (fr) 2013-03-14 2016-01-20 Hallux, Inc. Procédé de traitement d'infections, maladies ou troubles d'unité d'ongle
KR102320051B1 (ko) 2013-10-03 2021-10-29 다우 파마슈티컬 사이언시즈, 인코포레이티드 안정화된 에피나코나졸 조성물
CA3052643A1 (fr) 2013-11-22 2015-05-28 Bausch Health Ireland Limited Procedes, compositions et dispositifs anti-infectieux
EP2952208A1 (fr) 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Système hydroalcoolique de traitement des ongles
AR101510A1 (es) 2014-08-13 2016-12-21 Meiji Seika Pharma Co Ltd Agentes anti-trichophyton cristalinos y proceso de preparación de los mismos
US12115139B2 (en) 2018-08-15 2024-10-15 Todd Alan Weinfield Treatment methods and processes for an infected nail

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914131A (en) * 1971-08-23 1975-10-21 Emery Industries Inc Useful wax compositions
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
DE3520098A1 (de) * 1985-06-05 1986-12-11 Bayer Ag, 5090 Leverkusen Azolderivate enthaltende formulierungen sowie ihre verwendung zur atraumatischen nagelentfernung
CA1299098C (fr) * 1985-10-28 1992-04-21 John H. White Composes antimicrobiens a base d'alcool
DE3687458T2 (de) * 1985-11-04 1993-07-29 Owen Galderma Lab Inc Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
IL97012A0 (en) * 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails

Also Published As

Publication number Publication date
DE69420967D1 (de) 1999-11-04
ES2137372T3 (es) 1999-12-16
KR0179465B1 (ko) 1999-03-20
WO1995003775A1 (fr) 1995-02-09
JP3064423B2 (ja) 2000-07-12
CA2168248A1 (fr) 1995-02-09
DE69420967T2 (de) 2000-01-13
DK0711140T3 (da) 2000-01-03
CA2168248C (fr) 1999-03-16
KR960703558A (ko) 1996-08-31
ATE185066T1 (de) 1999-10-15
EP0711140A1 (fr) 1996-05-15
NZ267489A (en) 1999-09-29
US5391367A (en) 1995-02-21
GR3031897T3 (en) 2000-02-29
AU684826B2 (en) 1998-01-08
AU6979994A (en) 1995-02-28
JPH09504510A (ja) 1997-05-06
EP0711140B1 (fr) 1999-09-29

Similar Documents

Publication Publication Date Title
GR3031897T3 (en) Antifungal nail solution
CA2075060A1 (fr) Essences pour vehicules et leur utilisation dans des preparations medicales
GR3026627T3 (en) Transdermal application agent containing 3-keto-desogestrel.
GB2288732B (en) Pharmaceutical compositions
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
GB2357969A (en) Improvements in or relating to the treatment of lesions
AU9534398A (en) Novel pharmaceutical composition
AU6682594A (en) Treatment of septic shock
ZA949151B (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents.
GR3031354T3 (en) Soluble interferon -receptor, its preparation and use.
ZA935575B (en) Therapeutic agent and its use.
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
AU7655494A (en) Treatment of laminitis
CA2171728A1 (fr) Derives de triarylethylene pour utilisation therapeutique
AU580890B2 (en) P-acylaminobenzamides
ZA97902B (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis.
AU3262697A (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
AU5975094A (en) 1,2,4-triazinone derivatives and their use in therapy
CA2309653A1 (fr) Utilisation de la proteine h en tant qu'agent cytostatique
UA29639A (uk) Протипухлинний засіб
AU4096889A (en) The use of lactam derivatives in the treatment of depression
IT1269986B (it) Composizioni farmaceutiche a base di melatonina
EP1842538A3 (fr) Traitement pour le phénomène de Raynaud